Top Page
AML3D Ltd
(Sydney:AL3)
AML3D Ltd (AL3) vs. iShares MSCI Australia ETF (EWA)
AML3D Ltd Business Overview & Revenue Model
AML3D Ltd Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.44M | 7.39M | 7.32M | 634.42K | 2.01M | 644.00K |
| Gross Profit | 4.22M | 5.05M | 4.52M | -2.76M | -1.98M | -3.24M |
| EBITDA | -3.27M | -6.28M | -3.26M | -4.91M | -4.15M | -5.50M |
| Net Income | -4.05M | -7.40M | -4.17M | -5.44M | -4.90M | -5.51M |
Balance Sheet | ||||||
| Total Assets | 43.05M | 38.78M | 17.35M | 8.84M | 7.86M | 13.41M |
| Cash, Cash Equivalents and Short-Term Investments | 32.19M | 30.48M | 7.87M | 4.59M | 2.99M | 7.26M |
| Total Debt | 2.16M | 1.79M | 2.17M | 348.12K | 549.90K | 540.00K |
| Total Liabilities | 6.70M | 6.69M | 7.36M | 1.91M | 1.23M | 1.88M |
| Stockholders Equity | 36.35M | 32.09M | 9.99M | 6.93M | 6.63M | 11.53M |
Cash Flow | ||||||
| Free Cash Flow | -6.08M | -5.00M | -2.64M | -3.72M | -4.13M | -8.17M |
| Operating Cash Flow | -4.56M | -2.89M | -1.75M | -3.64M | -3.80M | -6.15M |
| Investing Cash Flow | -1.49M | -2.11M | -899.33K | 20.86K | -272.02K | -2.03M |
| Financing Cash Flow | 33.95M | 27.66M | 5.91M | 5.22M | -192.70K | 7.16M |
AML3D Ltd Technical Analysis
AML3D Ltd Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | AU$196.67M | 51.33 | 12.33% | 0.74% | 24.67% | 96.27% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ― | ― | ― | ― | 11.01% | -106.43% | |
57 Neutral | AU$113.00M | 35.59 | 5.66% | 1.27% | -14.88% | -56.89% | |
56 Neutral | AU$152.60M | -5.46 | -8.21% | ― | 3.30% | -294.63% | |
41 Neutral | AU$93.93M | -10.90 | -35.18% | ― | 0.88% | 4.88% |
AML3D Ltd Corporate Events
AML3D Limited has secured a significant order worth approximately $1.7 million for its ARCEMY® X system from FasTech LLC, a US-based supplier to the Defense, Aerospace, Energy, and other industrial sectors. This order not only enhances FasTech’s manufacturing capabilities but also strengthens AML3D’s presence in the US market. The ARCEMY® X system will be installed at FasTech’s facility near the U.S. Navy Additive Manufacturing Center of Excellence in Virginia and is expected to be operational by the third quarter of the 2026 financial year. This development is part of AML3D’s strategy to expand its footprint in the US by demonstrating the advantages of its additive manufacturing technology across various industrial sectors, thereby increasing demand for its systems and embedding itself further into the US manufacturing landscape.
AML3D Limited has released a disclaimer regarding the information contained in its presentation, emphasizing that the data has not been audited or verified. The company disclaims any liability for inaccuracies or omissions in the presentation and clarifies that it does not constitute an offer or recommendation to purchase securities. This announcement underscores AML3D’s cautious approach to communicating financial and operational projections, potentially impacting stakeholder expectations and market perception.
AML3D Limited announced significant progress in its ‘US Scale-up’ strategy, highlighted by the opening of a fully operational US Technology Centre in Stow, Ohio, to meet the demand from the US defence sector. The company received a Letter of Intent from the US Navy for up to 100 additive manufacturing systems and 1,600 components by 2030, and delivered its first ARCEMY® X system to the Tennessee Valley Authority, marking expansion beyond defence. Additionally, AML3D secured its first UK defence contract with BAE Systems and plans to establish a European Technology Centre to support its growth strategy in the UK and Europe. The company is investing AU$12 million to double its US manufacturing capacity and has set up distribution agreements to leverage opportunities in European markets.
AML3D Limited reported a quarterly revenue of A$2.5 million and highlighted significant growth opportunities within the U.S. Navy Maritime Industrial Base, supported by a Letter of Intent forecasting a demand for their ARCEMY® systems. The company secured an initial A$4.5 million order from Huntington Ingalls Industries, marking progress in converting this opportunity into sales. Additionally, AML3D is expanding its distribution capabilities in the U.K. and Europe, with plans to establish a European facility to meet growing demand. The company is also enhancing its U.S. operations by increasing ARCEMY® systems at its Technology Centre in Ohio and fulfilling orders for the U.S. Navy’s Additive Manufacturing Centre of Excellence.
AML3D Limited has secured a significant order worth approximately $4.5 million for two custom ARCEMY® systems from Newport News Shipbuilding, a division of HII, the largest military shipbuilder in the United States. This order marks the 9th and 10th ARCEMY® systems deployed to support the U.S. Navy’s Maritime Industrial Base, further solidifying AML3D’s presence in the defense sector. The integration of AML3D’s advanced additive manufacturing technology by HII aims to reduce lead times and offer alternatives to traditional manufacturing techniques, enhancing AML3D’s positioning in the U.S. and potentially expanding its footprint into European defense markets.
AML3D Ltd has announced the quotation of nearly 4 million fully paid ordinary securities on the Australian Securities Exchange (ASX) under the code AL3. This move is part of the company’s strategy to enhance its capital structure and potentially expand its market presence, reflecting its ongoing growth and development in the advanced manufacturing sector.
AML3D Ltd has announced its 2025 Annual General Meeting (AGM) scheduled for November 3, 2025, at KPMG’s offices in Adelaide. Shareholders are encouraged to participate in person or via proxy, with the opportunity to vote on resolutions and ask questions. This meeting is a critical event for stakeholders to engage with the company’s leadership and influence future decisions.
AML3D Ltd has announced that Andrew Michael Clayton Sales has ceased to be a substantial holder in the company as of September 23, 2025. This change was due to an on-market sale of 25,657,707 ordinary shares at $0.265 per share, which may impact the company’s shareholder structure and voting dynamics.
AML3D Limited announced that its Founder, Executive Director, and CTO, Mr. Andrew Sales, has sold 4.67% of the company’s issued capital, equating to 25,657,707 shares at $0.265 per share. Despite this sell-down, Mr. Sales remains committed to his roles within the company and is optimistic about growth opportunities in the US and European markets.
AML3D Ltd has released a presentation highlighting its international expansion strategy, leveraging a strong foundation in the US market. The company emphasizes that the information provided is not audited and contains projections that involve subjective judgment, disclaiming liability for any inaccuracies or omissions.